147 related articles for article (PubMed ID: 12166582)
1. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Humbert M; Labrune P; Sitbon O; Le Gall C; Callebert J; Hervé P; Samuel D; Machado R; Trembath R; Drouet L; Launay JM; Simonneau G
Eur Respir J; 2002 Jul; 20(1):59-65. PubMed ID: 12166582
[TBL] [Abstract][Full Text] [Related]
2. Severe pulmonary arterial hypertension in type 1 glycogen storage disease.
Humbert M; Labrune P; Simonneau G
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S93-6. PubMed ID: 12373580
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in glycogen storage disease type I.
Kishnani P; Bengur AR; Chen YT
J Inherit Metab Dis; 1996; 19(2):213-6. PubMed ID: 8739968
[No Abstract] [Full Text] [Related]
4. Stone forming risk factors in patients with type Ia glycogen storage disease.
Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
[TBL] [Abstract][Full Text] [Related]
5. Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib.
Wang DQ; Carreras CT; Fiske LM; Austin S; Boree D; Kishnani PS; Weinstein DA
Genet Med; 2012 Sep; 14(9):795-9. PubMed ID: 22678084
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in type I glycogen storage disease.
Hamaoka K; Nakagawa M; Furukawa N; Sawada T
Pediatr Cardiol; 1990 Jan; 11(1):54-6. PubMed ID: 2304882
[TBL] [Abstract][Full Text] [Related]
7. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
[TBL] [Abstract][Full Text] [Related]
8. Type I glycogen storage disease with vasoconstrictive pulmonary hypertension.
Furukawa N; Kinugasa A; Inoue F; Imashuku S; Takamatsu T; Sawada T
J Inherit Metab Dis; 1990; 13(1):102-7. PubMed ID: 2109144
[No Abstract] [Full Text] [Related]
9. Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques.
Koren E; Lipkin J; Klar A; Hershkovitz E; Ginsburg I; Kohen R
J Inherit Metab Dis; 2009 Oct; 32(5):651. PubMed ID: 19728140
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia.
Trioche P; Francoual J; Capel L; Odièvre M; Lindenbaum A; Labrune P
J Inherit Metab Dis; 2000 Mar; 23(2):107-12. PubMed ID: 10801051
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma serotonin in primary pulmonary hypertension.
Hervé P; Launay JM; Scrobohaci ML; Brenot F; Simonneau G; Petitpretz P; Poubeau P; Cerrina J; Duroux P; Drouet L
Am J Med; 1995 Sep; 99(3):249-54. PubMed ID: 7653484
[TBL] [Abstract][Full Text] [Related]
12. [Heterogeneous phenotypes in Chinese glycogen storage disease type Ia patients with homozygous G727T mutation].
Qiu ZQ; Wei M; Liu G; Liu GY
Zhonghua Er Ke Za Zhi; 2003 Apr; 41(4):252-5. PubMed ID: 14754525
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia.
Bandsma RH; Smit GP; Reijngoud DJ; Kuipers F
J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S27-31. PubMed ID: 19267215
[TBL] [Abstract][Full Text] [Related]
14. Type I glycogen storage disease with focal nodular hyperplasia of the liver and vasoconstrictive pulmonary hypertension.
Pizzo CJ
Pediatrics; 1980 Feb; 65(2):341-3. PubMed ID: 6928317
[No Abstract] [Full Text] [Related]
15. Pulmonary vascular disease in a child with atrial septal defect of the secundum type and type I glycogen storage disease.
Bolz D; Stocker F; Zimmermann A
Pediatr Cardiol; 1996; 17(4):265-7. PubMed ID: 8662053
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV
Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of serotonin and 5-hydroxyindoleacetic acid in blood plasma from patients with pulmonary hypertension due to mitral valve disease.
Kirillova VV; Nigmatullina RR; Dzhordzhikiya RK; Kudrin VS; Klodt PM
Bull Exp Biol Med; 2009 Apr; 147(4):408-10. PubMed ID: 19704935
[TBL] [Abstract][Full Text] [Related]
18. Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review.
Zhang B; Zeng X
Clin Rheumatol; 2016 Nov; 35(11):2851-2856. PubMed ID: 27139513
[TBL] [Abstract][Full Text] [Related]
19. A case of type Ia glycogen storage disease complicated by hepatic adenoma.
Fujiyama S; Sato K; Sakai M; Sato T; Tashiro S; Arakawa M
Hepatogastroenterology; 1990 Aug; 37(4):432-5. PubMed ID: 2170259
[TBL] [Abstract][Full Text] [Related]
20. A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported.
Karasawa Y; Kobayashi M; Nakano Y; Aoki Y; Kawa S; Kiyosawa K; Seki H; Kawasaki S; Furihata K; Itoh N
Am J Gastroenterol; 1998 Sep; 93(9):1550-3. PubMed ID: 9732943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
